According to AEON Biopharma's latest financial reports the company has ยฃ0.42 Million in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2022-12-31 | ยฃ8.05 M | 112.05% |
2021-12-31 | ยฃ3.79 M | -74.32% |
2020-12-31 | ยฃ14.79 M | -82.64% |
2019-12-31 | ยฃ85.21 M |